Figure 1.

Effects of conventional hyperglycemic PD solutions on the peritoneum. AGEs, advanced glycation end-products; CRP, c-reactive protein; GDPs, glucose degradation products; IL, interleukin; MCP-1, monocyte chemoattractant protein-1; MDA, malondialdehyde; NADPH, nicotinamide adenine dinucleotide phosphate; NF-kB, nuclear factor kB; NOS, nitric oxide synthase; PD, peritoneal dialysis; RAGE, AGE-receptor; TGF-β, transforming growth factor β; TNF, tumor necrosis factor; VEGF, vascular endothelial growth factor; 8-OH-dG, 8-hydroxy-2′-deoxyguanosine.